2 Profitable Stocks with Exciting Potential and 1 We Brush OffWhile profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
3 Stocks Under $10 with Questionable FundamentalsStocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying busi...
Consumer Discretionary - Real Estate Services Stocks Q1 In Review: RE/MAX (NYSE:RMAX) Vs PeersAs the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the consumer discretionary - real estate services industry, inclu...
Cushman & Wakefield and RE/MAX Shares Skyrocket, What You Need To KnowWhat Happened? A number of stocks jumped in the morning session after the Iran peace deal triggered a fall in Treasury yields that flows directly into mortga...
3 Consumer Stocks We Approach with CautionThe performance of consumer discretionary businesses is closely linked to economic cycles. Over the past six months, it seems like demand trends may be worki...
1 Russell 2000 Stock to Research Further and 2 Facing ChallengesThe Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...
Carriage Services, Deckers, and RE/MAX Shares Plummet, What You Need To KnowWhat Happened? A number of stocks fell in the afternoon session after oil prices approaching $98 per barrel renewed inflation concerns and reduced expectatio...
3 of Wall Street’s Favorite Stocks We’re Skeptical OfThe stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
3 Small-Cap Stocks We Steer Clear OfInvestors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Veris Residential, Inc. (NYSE – VRE), XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX)BALA CYNWYD, Pa., May 14, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Kontoor Brands and RE/MAX Shares Are Falling, What You Need To KnowWhat Happened? A number of stocks fell in the afternoon session after Brent crude surged, erasing the brief oil relief from the previous week as consumer sen...
RE/MAX (NYSE:RMAX) Misses Q1 CY2026 Sales ExpectationsReal estate franchise company RE/MAX (
NYSE:RMAX) fell short of the market’s revenue expectations in Q1 CY2026, with sales falling 5.7% year on year to $70.23...
RMAX Investigation News: RE/MAX Holdings Board Investigated Over $13.80 Merger Announcement – Contact BFA Law to Protect Your Rights
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into RE/MAX Holdings, Inc.’s (
NYSE: RMAX) board of directors as well as RE/MAX co-founder and chairman David Liniger. The investigation focuses on potential breaches of fiduciary duties to shareholders in connection with the pending merger between RE/MAX and The Real Brokerage Inc. announced on April 27, 2026.
Earnings To Watch: RE/MAX (RMAX) Reports Q1 Results TomorrowReal estate franchise company RE/MAX (
NYSE:RMAX) will be reporting results this Thursday after market hours. Here’s what investors should know. RE/MAX met an...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)BALA CYNWYD, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
3 Stocks Under $50 with Open QuestionsThe $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
1 Value Stock with Exciting Potential and 2 We Turn DownValue stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
